Characterization of the polymorphic behavior of an organic compound using a dynamic thermal and X-ray powder diffraction technique

被引:5
|
作者
Albers, David
Galgoci, Michelle
King, Dan
Miller, Daniel
Newman, Robert
Peerey, Linda
Tai, Eva
Wolf, Richard
机构
[1] Dow Chem Co USA, Dept Analyt Sci, Midland, MI 48674 USA
[2] Dow Chem Co USA, Dowpharma Dept, Midland, MI 48674 USA
关键词
D O I
10.1021/op700037w
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The crystalline polymorphic forms of several samples of an organic compound produced by Dowpharma were characterized using differential scanning calorimetry (DSC); X-ray powder diffraction (XRPD); combined, simultaneous, and dynamic differential scanning calorimetry/X-ray powder diffraction (DSC/XRPD); and high performance liquid chromatography (HPLC). A total of 10 crystalline polymorphs were identified, six of which are anhydrous. Form I is a heptahydrate that reversibly converts to anhydrous Form I under dry conditions and also undergoes a reversible solid-solid phase transition at about 110 degrees C to convert to Form H. Form Il is anhydrous and melts at approximately 220 degrees C. Form III crystallizes as a hexahydrate, which reversibly converts to the monohydrate Form III and then to an anhydrous Form III above 120 degrees C. Anhydrous Form III melts at approximately 200 degrees C. Form IN crystallized as a hydrous material, which was converted to the anhydrous Form IN above approximately 60 degrees C, in a reversible process. Form W appears to be unstable in high humidity conditions (e.g., 90% relative humidity at 25 degrees C and slowly converts to Forms I and III. Form IN also undergoes a nonreversible solid-solid, phase transition at approximately 180 degrees C, to form anhydrous Form V. Form V melts at approximately 245 degrees C. Form VI is observed only in the anhydrous state and melts at approximately 245 degrees C. The anhydrous nature of Form VI makes this material the most ideal crystalline material for subsequent formulation work.
引用
收藏
页码:846 / 860
页数:15
相关论文
共 50 条
  • [1] Characterization of polymorphic solid-state changes using variable temperature X-ray powder diffraction
    Karjalainen, M
    Airaksinen, S
    Rantanen, J
    Aaltonen, J
    Yliruusi, J
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 39 (1-2) : 27 - 32
  • [2] REVISED X-RAY POWDER DIFFRACTION TECHNIQUE
    JOHNSON, GG
    INDUSTRIAL AND ENGINEERING CHEMISTRY, 1969, 61 (05): : 79 - &
  • [3] X-ray powder diffraction data for compound DyNiSn
    Nong, LQ
    Zeng, LM
    Hao, JM
    POWDER DIFFRACTION, 1997, 12 (03) : 134 - 135
  • [4] X-ray powder diffraction data for compound DyNiSn
    Nong, Liangqin
    Zeng, Lingmin
    Hao, Jianmin
    Powder Diffraction, 1997, 12 (03): : 134 - 135
  • [5] X-ray Powder Diffraction Characterization of Nanoparticles
    Giannini, Cinzia
    Guagliardi, Antonietta
    Zanchet, Daniela
    Cervellino, Antonio
    Ladisa, Massimo
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2005, 61 : C405 - C405
  • [6] X-ray Powder Diffraction Characterization of Pyrope
    王冠鑫
    龚国洪
    Acta Geochimica, 1990, (03) : 284 - 288
  • [7] Particle Characterization by X-ray Powder Diffraction
    Herrmann, Michael
    Foerter-Barth, Ulrich
    Kempa, Paul Bernd
    Kroeber, Hartmut
    CHEMICAL ENGINEERING & TECHNOLOGY, 2009, 32 (07) : 1067 - 1072
  • [8] Product characterization by X-ray powder diffraction
    McCusker, LB
    MICROPOROUS AND MESOPOROUS MATERIALS, 1998, 22 (4-6) : 527 - 529
  • [9] Quantification of febuxostat polymorphs using powder X-ray diffraction technique
    Qiu, Jing-bo
    Li, Gang
    Sheng, Yue
    Zhu, Mu-rong
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2015, 107 : 298 - 303
  • [10] Quantification of olanzapine polymorphs using powder X-ray diffraction technique
    Tiwari, Manisha
    Chawla, Garima
    Bansal, Arvind K.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 43 (03) : 865 - 872